NEW: EVE Analytics

A solution for unbiased, non-invasive, continuous analysis & quantification in live cell imaging
Learn more

Nanolive microscopes

 Swiss high precision microscopes that look instantly inside label-free living cells in 3D

Book a demo or get a quote >


Automated live cell imaging: a unique walk-away solution for long-term live cell imaging of single cells and cell populations

Learn more >


Multimodal Complete Solution: combine high quality non-invasive 4D live cell imaging with fluorescence

Learn more >

3D Cell Explorer front view


Budget-friendly, easy-to-use, compact solution for high quality non-invasive 4D live cell imaging

Learn more >

Latest News

Antibody-fusion OPS-121_final

Nanolive imaging validates antibody efficacy in the fight against cancer

What is the role of macrophages in the immune response? Macrophages are a type of white blood cell present in our innate immune system. They are specialized effector cells that detect and destroy harmful pathogens (e.g., bacteria or viruses), as well as diseased and damaged cells via an engulfment process known as phagocytosis. Antigen peptides, the products of phagocytosis, are presented to major histocompatibility complex (MHC) class II molecules present on the surface of the macrophage,...
EVE Analytics for 3D Cell Explorer-fluo

EVE Analytics for the 3D Cell Explorer-fluo

Continuous, multiplexed live cell data, multi-parametric readout EVE Analytics’ user-friendly interface offers a segmentation and analysis solution specific to Nanolive’s content rich data which can deliver meaningful metrics with the highest biological relevance. Works over long-term experiments where cell confluency changes significantly with no reduction in quality and automatically calculates and delivers numerous live cell metrics in parallel such as dry mass, cell count, cell confluency,...

Investigating the cellular adhesion process in non‐small cell lung cancer cells using Nanolive imaging

Lung cancer: the world's deadliest cancer The World Health Organization (WHO) reports lung cancer as the most common cause of cancer death in 2020. It is estimated to have caused 1.8 million deaths worldwide, 85% of which, were classified as non‐small cell lung cancers (NSCLC). Only 19% of patients diagnosed with NSCLC survive for longer than 5 years. This worryingly low figure reflects the difficulties in diagnosing early stages of lung cancer (~40% of NSCLC diagnoses made are already at...

At Nanolive, we focus on innovative product development at the highest standards to deliver a high precision and quality research device for our international customers.

Receive our latest news

Register for our newsletter!